Leading experts illustrate how sophisticated computational data mining techniques can impact contemporary drug discovery and development
In the era of post-genomic drug development, extracting and applying knowledge from chemical, biological, and clinical data is one of the greatest challenges facing the pharmaceutical industry. Pharmaceutical Data Mining brings together contributions from leading academic and industrial scientists, who address both the implementation of new data mining technologies and application issues in the industry. This accessible, comprehensive collection discusses important theoretical and practical aspects of pharmaceutical data mining, focusing on diverse approaches for drug discovery―including chemogenomics, toxicogenomics, and individual drug response prediction. The five main sections of this volume cover:
In one concentrated reference, Pharmaceutical Data Mining reveals the role and possibilities of these sophisticated techniques in contemporary drug discovery and development. It is ideal for graduate-level courses covering pharmaceutical science, computational chemistry, and bioinformatics. In addition, it provides insight to pharmaceutical scientists, principal investigators, principal scientists, research directors, and all scientists working in the field of drug discovery and development and associated industries.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Konstantin V. Balakin is Head of the Laboratory of Information Technology in Medicinal Chemistry at the Institute of Physiologically Active Compounds at the Russian Academy of Sciences. He is also Director of the scientific consortium "Orchemed" (Organic Chemistry and Medicine), which currently includes 11 Russian academic institutes working in the field of organic, medicinal and biological chemistry, and drug discovery. Previously, he was Head of the Computational Chemistry Department at ChemDiv, Inc.¿Dr. Balakin¿is the author or coauthor of more than 90 peer reviewed research articles, reviews, and book chapters. He is the principal developer of the SmartMining and InformaGenesis software tools, which are special programs for pharmaceutical multivariate data mining.
Leading experts illustrate how sophisticated computational data mining techniques can impact contemporary drug discovery and development
In the era of post-genomic drug development, extracting and applying knowledge from chemical, biological, and clinical data is one of the greatest challenges facing the pharmaceutical industry. Pharmaceutical Data Mining brings together contributions from leading academic and industrial scientists, who address both the implementation of new data mining technologies and application issues in the industry. This accessible, comprehensive collection discusses important theoretical and practical aspects of pharmaceutical data mining, focusing on diverse approaches for drug discovery―including chemogenomics, toxicogenomics, and individual drug response prediction. The five main sections of this volume cover:
In one concentrated reference, Pharmaceutical Data Mining reveals the role and possibilities of these sophisticated techniques in contemporary drug discovery and development. It is ideal for graduate-level courses covering pharmaceutical science, computational chemistry, and bioinformatics. In addition, it provides insight to pharmaceutical scientists, principal investigators, principal scientists, research directors, and all scientists working in the field of drug discovery and development and associated industries.
Leading experts illustrate how sophisticated computational data mining techniques can impact contemporary drug discovery and development
In the era of post-genomic drug development, extracting and applying knowledge from chemical, biological, and clinical data is one of the greatest challenges facing the pharmaceutical industry. Pharmaceutical Data Mining brings together contributions from leading academic and industrial scientists, who address both the implementation of new data mining technologies and application issues in the industry. This accessible, comprehensive collection discusses important theoretical and practical aspects of pharmaceutical data mining, focusing on diverse approaches for drug discovery—including chemogenomics, toxicogenomics, and individual drug response prediction. The five main sections of this volume cover:
In one concentrated reference, Pharmaceutical Data Mining reveals the role and possibilities of these sophisticated techniques in contemporary drug discovery and development. It is ideal for graduate-level courses covering pharmaceutical science, computational chemistry, and bioinformatics. In addition, it provides insight to pharmaceutical scientists, principal investigators, principal scientists, research directors, and all scientists working in the field of drug discovery and development and associated industries.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABBB-201077
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABBB-51542
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. xvi + 561 Illus. Artikel-Nr. 8152570
Anzahl: 1 verfügbar
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. Konstantin V. Balakin is Head of the Laboratory of Information Technology in Medicinal Chemistry at the Institute of Physiologically Active Compounds at the Russian Academy of Sciences. He is also Director of the scientific consortium Orchemed (Organic Ch. Artikel-Nr. 556554735
Anzahl: Mehr als 20 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Extracting and applying knowledge from chemical, biological, and clinical data is one of the biggest problems for the pharmaceutical industry. Series Editor(s): Ekins, Sean. Series: Wiley Series on Technologies for the Pharmaceutical Industry. Num Pages: 562 pages, Illustrations. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 233 x 163 x 31. Weight in Grams: 912. . 2009. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Artikel-Nr. V9780470196083
Anzahl: 15 verfügbar